Viewing StudyNCT00408499



Ignite Creation Date: 2024-05-05 @ 5:12 PM
Last Modification Date: 2024-10-26 @ 9:29 AM
Study NCT ID: NCT00408499
Status: COMPLETED
Last Update Posted: 2017-05-08
First Post: 2006-12-06

Brief Title: Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer
Sponsor: University of California Davis
Organization: University of California Davis

Organization Data

Organization: University of California Davis
Class: OTHER
Study ID: CDR0000517090
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of California Davis
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH